Cardiac Pathways' Acquisition

Cardiac Pathways was acquired by Boston Scientific Corporation on August 10, 2001.

Cardiac Pathways manufactures minimally invasive systems used by electrophysiologists to diagnose and treat cardiac tachyarrhythmias, which if untreated can cause palpitations, fainting, and sudden ca…

Articles about Cardiac Pathways' Acquisition: